ArticleAnnals of translational medicine2021

Preclinical efficacy and safety evaluation of interleukin-6-knockdown CAR-T cells targeting at CD19.

Hairuo Wen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.